Current clinical trial research
Help beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Saving lives through our research
Our clinical trials recruit over 25,000 patients on average every year. Clinical trials are vital for developing new treatments, making sure they are safe and better than current ones. Below are some examples of what our researchers are doing right now.
Our current researchers
Running a trial for a rare womb cancer
Professor Helena Earl is leading a clinical trial for women with a rare type of womb cancer – high grade sarcoma. The trial, being coordinated from Glasgow, aims to find out whether using a new, targeted drug after chemotherapy could improve outlook. The results from the trial could change the way these women are treated in future.
Professor Andrew Biankin in Glasgow is leading PRECISION-Panc. This ambitious study is uncovering the biological characteristics of patients’ pancreatic tumours to learn more about the biology of the disease. The aim is to use this information to match pancreatic cancer patients to the best clinical trial for them.
Directing the Cancer Research UK Clinical Trials Unit
Professor Pam Kearns is Director of the Cancer Research UK Clinical Trials Unit (CRCTU) in Birmingham. The unit coordinates clinical trials across the UK to find new, better and kinder ways to treat the different cancers that affect children and young people. As part of their work, the CRCTU works with scientists across the world to develop these new trials and treatments.
Heading clinical trials for lymphoma
Professor Peter Johnson in Southampton is a lymphoma expert and leads several lymphoma clinical trials across the UK. He also leads a group of researchers who are studying how to use molecular testing to find better treatments that include new, targeted drugs.
Trialling a 'sponge-on-a-string' test
Professor Rebecca Fitzgerald in Cambridge is running a trial in GP surgeries around the UK to test a new test called ‘sponge-on-a-string’, or ‘Cytosponge’. When coupled with a simple laboratory test it can be used to diagnose Barrett’s oesophagus, a condition that can develop into oesophageal cancer. Identifying people with this condition and monitoring them over time could help doctors diagnose oesophageal cancer earlier. The aim is to determine whether it is cheaper and easier than current methods used to diagnose Barrett’s oesophagus with this new test.